Lucis
Paris, France
◆ Total Raised
$18.8M
◆ Stage
series-a
◆ Location
Paris, France
◆ Founded
2025
◆ Team size
1-10
◆ Links
◆ About Lucis
AI-driven preventive healthcare platform combining biomarker testing, longitudinal health data and physician-reviewed AI insights to help users detect health risks earlier.
◆ What sets it apart
It combines comprehensive biomarker testing, AI analysis, and physician review to convert routine blood tests into ongoing preventive health guidance.
◆ Sectors
◆ Business
ModelSaaS
CustomerConsumers seeking preventive health screening and personalized health guidance
◆ Notable
- Raised $8.5M seed funding
- Served 3,000 customers
- Conducted over 500,000 clinical tests
- Built a network of 400+ European laboratories
◆ Funding rounds
◆ Explore the market
◆ FAQ
What does Lucis do?
AI-driven preventive healthcare platform combining biomarker testing, longitudinal health data and physician-reviewed AI insights to help users detect health risks earlier.
Where is Lucis based?
Lucis is based in Paris, France, founded in 2025.
How much has Lucis raised?
Lucis has raised $18.8M in tracked funding and is currently at the series-a stage.
Who has invested in Lucis?
Investors in Lucis include General Catalyst, Y Combinator, Kima Ventures, Motier Ventures, Circle.Co and North South Ventures.